Repurposing Pirfenidone for Nonalcoholic Steatohepatitis-related Cirrhosis: A Case Series

We repurposed the antifibrotic drug pirfenidone—which is approved for treatment of idiopathic lung fibrosis—in a series of patients with nonalcoholic steatohepatitis-related cirrhosis. Our report demonstrates the observed improvements in necroinflammation and regression of cirrhosis with pirfenidone...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Transl Hepatol
Main Authors: Philips, Cyriac Abby, Padsalgi, Guruprasad, Ahamed, Rizwan, Paramaguru, Rajaguru, Rajesh, Sasidharan, George, Tom, Mahadevan, Pushpa, Augustine, Philip
Formato: Artigo
Idioma:Inglês
Publicado em: XIA & HE Publishing Inc. 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7132022/
https://ncbi.nlm.nih.gov/pubmed/32274350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2019.00056
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados